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Iron regulatory protein 2 (IRP2) is a critical switch for cellular and systemic iron homeostasis. In
iron-deﬁcient or hypoxic cells, IRP2 binds to mRNAs containing iron responsive elements (IREs)
and regulates their expression. Iron promotes proteasomal degradation of IRP2 via the F-box pro-
tein FBXL5. Here, we explored the effects of oxygen and cellular redox status on IRP2 stability. We
show that iron-dependent decay of tetracycline-inducible IRP2 proceeds efﬁciently under mild hyp-
oxic conditions (3% oxygen) but is compromised in severe hypoxia (0.1% oxygen). A treatment of
cells with exogenous H2O2 protects IRP2 against iron and increases its IRE-binding activity. IRP2
is also stabilized during menadione-induced oxidative stress. These data demonstrate that the deg-
radation of IRP2 in iron-replete cells is not only oxygen-dependent but also sensitive to redox
perturbations.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Iron regulatory proteins 1 and 2 (IRP1 and IRP2) are homolo-
gous cytoplasmic RNA-binding proteins that control cellular iron
metabolism in vertebrates [1–3]. IRPs are also crucial for mainte-
nance of systemic iron homeostasis [4] and may exert additional
iron-independent functions [5,6]. Under conditions of iron deﬁ-
ciency, IRPs interact with iron responsive elements (IREs) in the
untranslated regions of various mRNAs promoting translational
repression or stabilization. In iron-replete cells, IRP1 undergoes a
conformational change upon assembly of an aconitase-type cubane
[4Fe–4S] cluster that prevents RNA-binding [7], while IRP2 is de-
graded by the proteasome following ubiquitination [8]. When
iron–sulfur cluster biogenesis is defective, apo-IRP1 may also un-
dergo iron-dependent proteasomal degradation, albeit with sub-
stantially lower efﬁciency as compared to IRP2 [9].
IRP2 (and apo-IRP1) are substrates of FBXL5, an F-box protein
that assembles together with Skp1, Cul1 and Rbx1 into an E3chemical Societies. Published by E
protein 1 and 2; IRE, iron
Fa, hypoxia inducible factor
e; HA, hemagglutinin




k.ubiquitin ligase complex [10,11]. FBXL5 contains an N-terminal
hemerythrin domain that binds an Fe–O–Fe center, with iron and
oxygen sensing properties. The Fe–O–Fe center is formed in iron-
replete and oxygenated cells and confers stability to FBXL5, which
in turn interacts with IRP2 and promotes its ubiquitination and
degradation. By contrast, in iron-deﬁcient or hypoxic cells, apo-
FBXL5 undergoes proteasomal degradation itself, resulting in
IRP2 accumulation. This model is in tune with the earlier reported
stabilization of IRP2 by hypoxia [12].
Structural elements of IRP2 that sensitize the protein to iron-
dependent degradation have not been identiﬁed thus far, and the
molecular interaction between IRP2 and FBXL5 has not been char-
acterized in details. An IRP2-speciﬁc stretch of 73 amino acids close
to its N-terminus was earlier proposed to function as iron sensor
[13]; however, this polypeptide is sensitive to iron-independent
cleavage [14] and IRP2 deletion mutants lacking the entire 73 ami-
no acids region remain vulnerable to iron [15,16]. Deletion of
C-terminal fragments stabilize IRP2 against iron, but it appears
that the protein lacks any speciﬁc ‘‘iron-dependent degradation
domain’’. In fact, iron sensing by IRP2 requires preservation of its
structural integrity [17].
Considering that several antioxidants promote IRP2 degradation
[16], we explored here the possibility for redox regulation of IRP2.
We show that IRP2 degradation in response to iron requires oxy-
gen. Furthermore, we demonstrate that oxidative stress stabilizes
IRP2 and modulates the expression of downstream targets. These
ﬁndings are consistent with the central role of FBXL5 in IRP2lsevier B.V. All rights reserved.
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ways underlying the redox control of IRP2 stability.
2. Materials and methods
2.1. Reagents
Ferric ammonium citrate and menadione were purchased from
Sigma (St. Louis, MI) and desferrioxamine (DFO) from Novartis
(Dorval, QC). Ascorbate and H2O2 were purchased from Bioshop
(Burlington, ON).
2.2. Cell culture
Human H1299 lung cancer cells [16] and mouse Ltk-ﬁbroblasts
[18] were maintained in Dulbecco’s modiﬁed Eagle medium
(DMEM) supplemented with 10% heat-inactivated fetal bovine ser-
um (FBS), 100 units/ml penicillin, and 0.1 ng/ml streptomycin.
RAW 264.7 macrophages (ATCC number CRL-2278™) were cul-
tured in RPMI-1640 medium including supplements. Cells were
incubated at 37 C with 5% CO2. H1299 stable clones overexpress-
ing hemagglutinin (HA)-tagged IRP2 [16] were maintained in med-
ia containing 2 lg/ml tetracycline, 2 lg/ml puromycin and 250 lg/
ml G418. The expression of IRP2-HA was induced by removal of
tetracycline (tet-off) in media supplemented with 10% heat-inacti-
vated Tet System Approved FBS (Clontech) for 48 h.
2.3. Western blotting
Cells were washed twice in cold phosphate buffered saline (PBS)
and lysed for 20 min in RIPA buffer, containing PBS, 1% Nonidet P-
40, 0.5% sodium deoxycholate, 0.1% SDS and a protease inhibitor
cocktail (Sigma). Cell debris was cleared by centrifugation and pro-
tein concentration was measured with the Bradford reagent
(BioRad). All cell lysates (40 lg of proteins) were denatured for
10 min at 95 C. The proteins were analyzed by SDS–PAGE on 8%
gels and transferred onto nitrocellulose membranes. The mem-
branes were blocked in 10% non-fat milk in Tris-buffered saline
containing 0.1% Tween 20 (TBS-T) and probed overnight at 4 C
with primary antibodies (diluted in TBS-T with 5% non-fat milk):
1:250 HIF-1a (BD Biosciences), 1:500 ferritin (Novus) and 1:1000
HA (Roche), or b-actin (Sigma). Following three washes with TBS-
T, the blots with b-actin antibodies were incubated with 1:15000
diluted peroxidase-coupled goat anti-rabbit IgG (Sigma) for 2 h.
The blots with HIF-1a antibodies were incubated with 1:5000 di-
luted peroxidase-coupled rabbit anti-mouse IgG (Sigma) for 2 h.
The blots with HA antibody was incubated with 1:5000 diluted
peroxidase-coupled goat anti-rat IgG (Roche) for 2 h. Following
three washes with TBS-T, detection was performed with the en-
hanced ECL method (Perkin Elmer).
2.4. Electrophoretic mobility shift assay (EMSA)
A human ferritin H-chain IRE probe [19] was radiolabeled with
[a-32P]-UTP and subsequently puriﬁed from unincorporated nucle-
otides and salts by passing twice through a G-50 micro-spin col-
umn (ProbeQuant). The radiolabeled probe was denatured for
1 min at 95 C. Cells were lysed in cytoplasmic lysis buffer (1% Tri-
ton X-100, 40 mM KCl, 25 mM Tris–Cl, pH 7.4) containing 1 mM
dithiothreitol. Cell debris was cleared by centrifugation and pro-
tein concentration was measured with the Bradford reagent (Bio-
Rad). Cell lysates containing 2 lg protein were incubated with
the 32P-labeled IRE probe and 50 lg heparin. The reaction was
loaded on a 6% non-denaturing polyacrylamide gel and separatedat 4 C. Gels were dried and radioactive bands were visualized by
autoradiography.
2.5. Hypoxia
Cells were placed in a humidiﬁed (37 C) hypoxic glove box
with a gas mixing system (Coy Laboratory Products). Hypoxic envi-
ronment was maintained at 3% or 0.1% O2, and 5% CO2 with a bal-
ance of nitrogen. Lysates of hypoxic cells were prepared inside the
box.
2.6. Statistical analysis
Quantitative data were expressed as means ± standard devia-
tion (S.D.). Statistical analysis was performed by using the two-
tailed Student’s t-test with the GraphPad Prism software (v. 5.0c).
A probability value P < 0.05 was considered to be statistically
signiﬁcant.
3. Results
3.1. IRP2 degradation in response to iron requires oxygen
To address the effects of oxygen on iron-mediated degradation
of IRP2, we employed previously characterized H1299 cells
expressing HA-tagged IRP2 in a tetracycline-inducible fashion
[16]. Removal of tetracycline for 48 h results in accumulation of
an IRP2 pool (Fig. 1A, lane 2). Re-addition of the drug shuts off
new IRP2 synthesis and allows studies on IRP2 stability. In light
of the stabilizing effects of hypoxia on IRP2 [12], we ﬁrst examined
whether iron promotes degradation of the IRP2 pool under variable
oxygen concentrations. The cells were incubated under 21%, 3% or
0.1% O2 for 0, 4 or 8 h, in the absence or presence of exogenous fer-
ric ammonium citrate (FAC).
As expected, in ambient oxygen concentration (21% O2) iron
dramatically accelerated IRP2 turnover (Fig. 1A, lanes 1–7); the
kinetics were consistent with previous pulse-chase experiments
showing that iron decreases IRP2 half-life from 5.5 to 1.5 h [16].
In moderate (3% O2), as well as in severe hypoxia (0.1% O2), IRP2
was stable throughout the 8 h time course (lanes 8–10 and 14–
16, respectively), in agreement with earlier ﬁndings [12,15]. The
administration of FAC efﬁciently promoted IRP2 degradation in
moderate hypoxia (lanes 11–13). However, under severe hypoxic
conditions, IRP2 was strongly protected after 4 h exposure to FAC
and underwent only partial degradation after 8 h (lanes 17–19).
All treatments did not alter the expression of endogenous control
b-actin (lower panels), while the upregulation of HIF-1a expres-
sion (Fig. 1B) in cells exposed to 3% or 0.1% O2 indicates the efﬁ-
ciency of the hypoxic treatment. These data demonstrate that the
degree of hypoxia affects the sensitivity of IRP2 to iron and further-
more, suggest that the iron-dependent degradation of IRP2 re-
quires a threshold of oxygen.
3.2. H2O2 stabilizes IRP2 and modulates the expression of IRP2 targets
Considering that oxidative stress mimics hypoxia and stabilizes
hypoxia inducible factor a (HIFa) subunits by decreasing the activ-
ity of HIF prolyl-hydroxylases [20], we analyzed the effects of H2O2
on IRP2 decay. The cells were ﬁrst induced to express IRP2 (Fig. 2A,
lane 2). The addition of 1 mM H2O2 promoted stabilization of IRP2
over 8 h (compare lanes 3 and 4 with 6 and 7), without affecting
cell viability. Moreover, the H2O2 treatment partially protected
IRP2 against iron-dependent degradation within 4 h (compare
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Fig. 1. Severe hypoxia impairs iron-mediated degradation of IRP2. H1299 cells were grown for 48 h with 2 lg/ml or without tetracycline, to induce expression of IRP2-HA. At
t(h) = 0, tetracycline (2 lg/ml) was added back to the culture media and the cells were incubated for the indicated time intervals in the absence or presence of 30 lg/ml FAC at
21%, 3% or 0.1% O2. (A) The expression of IRP2-HA and b-actin was analyzed by Western blotting. Data from four independent experiments were quantiﬁed by densitometry
and relative IRP2-HA band intensities (means ± S.D.) were normalized with the respective b-actin values and plotted below. (B) The expression of HIF-1a and b-actin was
analyzed by Western blotting. ⁄⁄P < 0.01 (Student’s t-test).
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panel), which serves as a loading control.
The stabilization of IRP2 was also evident after 12 h exposure to
a bolus of H2O2 (Fig. 2B), despite the fact that extracellular H2O2 is
rapidly metabolized by cultured cells [21,22]. We chose this time
point to avoid possible interference with an early transient H2O2-
mediated activation of IRP1 [18,21], and assess the implications
of IRP2 stabilization on IRE-binding activity and expression of
IRE-containing mRNAs. We then evaluated the effects of H2O2-
mediated stabilization of IRP2 in the expression of two known
IRP downstream targets, ferritin and transferrin receptor 1 (TfR1).
Ferritin, an iron storage protein, is negatively regulated by IRPs
at the translational level, while TfR1, the protein involved in the
uptake of transferrin-bound iron from circulation, is positively reg-
ulated by IRPs at the level of mRNA stability [1–3]. The stabiliza-
tion of IRP2 by H2O2 (Fig. 2B, panel 1) was accompanied by a
profound decrease in ferritin content (panel 2) and a 20% stimu-
lation of TfR1 expression (panel 3), while b-actin levels remained
unchanged (panel 4).
Because IRE/IRP1 and IRE/IRP2 complexes from mouse extracts
migrate differently in electrophoretic mobility shift assays [18], we
employed murine Ltk-ﬁbroblasts to directly assess the implications
of H2O2-mediated protection of endogenous IRP2 against iron-
dependent degradation on its IRE-binding activity. Indeed, admin-
istration of H2O2 to DFO-pretreated Ltk-cells for 4 h antagonized
the loss of IRE-binding activity of IRP2 in response to FAC
(Fig. 2C, lanes 7 and 9). Interestingly, the simultaneous presence
of ascorbate abolished the protective effects of H2O2 (lane 10). Sim-
ilar results were obtained with RAW macrophages (data not
shown). Taken together, the above data suggest that H2O2 can
modulate cellular iron metabolism via stabilization of IRP2 and
induction of its IRE-binding activity, which in turn is capable of
inhibiting ferritin mRNA translation and protecting TfR1 mRNA
against degradation by binding to their respective IREs.3.3. Effects of menadione and ascorbate on IRP2 stability
Menadione, a redox cycling quinone, generates oxidative stress
in cultured cells [23]. A treatment of H1299 cells with 100 lM
menadione resulted in IRP2 stabilization (Fig. 3A, compare lanes
1–4 with 5–7). This effect persisted even in the presence of excess
(2.5 mM) ascorbate (lanes 11–13), that is known to promote IRP2
turnover (lanes 1–7 and [16]). We next examined the effects of
ascorbate on other known IRP2 stabilizers. Ascorbate efﬁciently
inhibited IRP2 stabilization by the hypoxia-mimetic cobalt chloride
(Fig. 3B, lanes 1 and 2). By contrast, ascorbate failed to signiﬁcantly
decrease IRP2 levels in cells treated with the iron chelator DFO
(lanes 3 and 4), or exposed to severe hypoxia (lanes 5 and 6).
4. Discussion
Aiming to better understand the biochemistry of IRP2 regula-
tion, we examined how oxygen and oxidative stress affect the sen-
sitivity of this protein towards iron. Iron triggers ubiquitination
and degradation of IRP2 via the proteasome [8] by a mechanism
involving FBXL5, a component of an E3 ubiquitin ligase complex
with iron sensing capacity via its hemerythrin domain [10,11].
Hypoxia destabilizes FBXL5 upon loss of its Fe–O–Fe center, which
allows accumulation of IRP2. Consistently with published litera-
ture, we observed increased expression of IRP2 and HIFa (as posi-
tive control) in hypoxic cells (Fig. 1). The stabilization of IRP2 by
hypoxia was ﬁrst reported by Leibold and co-workers [12]; in this
work, it was also shown that endogenous IRP2 remains sensitive to
degradation in iron-loaded HEK293 cells exposed to 1% O2, leading
to the conclusion that ‘‘the IRP2 response to iron is not impaired
during hypoxia’’ [12]. Here we conﬁrm these ﬁndings in a different
experimental setting of ‘‘mild’’ hypoxia (Fig. 1A, lanes 8–13), even
though a concentration of 3% O2 may be physiologically relevant in
tissues [24]. We further demonstrate that severe (0.1% O2) hypoxia
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Fig. 2. H2O2 stabilizes IRP2, induces its IRE-binding activity and modulates the expression of IRP2 downstream targets. (A) H1299 cells were grown for 48 h with 2 lg/ml or
without tetracycline, to induce expression of IRP2-HA. At t(h) = 0, tetracycline (2 lg/ml) was added back to the cell culture media and the cells were treated for the indicated
time intervals with 1 mM H2O2 or not, in the presence (+) or absence () of 30 lg/ml FAC. In (A), the expression of IRP2-HA and b-actin was analyzed by Western blotting.
Data from three independent experiments were quantiﬁed by densitometry and relative IRP2-HA band intensities (means ± S.D.) were normalized with the respective b-actin
values and plotted on the right. (B) In a ‘‘tetracycline add-back’’ experiment, the cells were either remained untreated () or treated with (+) 1 mM H2O for 12 h. Cell lysates
were subjected to Western blotting with antibodies against, transferrin receptor 1 (TfR1), HA (for IRP2), ferritin and b-actin. (C) Ltk-cells were either pretreated for 16 h with
100 lM DFO to increase endogenous IRP2 levels or not, and subsequently washed and treated for 4 h with either 30 lg/ml FAC, 1 mM H2O2, or 1 mM ascorbate, as indicated.
Cytoplasmic extracts were analyzed for IRE-binding activity with a 32P-labeled IRE probe. The positions of the IRE/IRP1 and IRE/IRP2 complexes and unbound free probes are
indicated by arrows. The data are representative of three independent experiments. ⁄⁄P < 0.01 (Student’s t-test).

























Fig. 3. IRP2 stabilization by menadione and effects of ascorbate on IRP2 stabilizers.
H1299 cells were grown for 48 h without tetracycline, to induce expression of IRP2-
HA. At t(h) = 0, tetracycline (2 lg/ml) was added back to the cell culture media. In
(A), the cells were treated for the indicated time intervals with 100 lM menadione
or not, in the presence (+) or absence () of 2.5 mm ascorbate. In (B), the cells were
treated for 8 h with 100 lM cobalt chloride (Co2+), or 100 lM DFO, or exposed to
severe hypoxia (0.1% O2), in the absence () or presence (+) of 2.5 mM ascorbate.
The expression of IRP2-HA and b-actin was analyzed by Western blotting. The data
are representative of three independent experiments.
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early time intervals (Fig. 1A, lanes 14–18). Taken together, thesedata suggest that the degradation of IRP2 by iron involves an oxy-
gen-dependent mechanism, in line with the indispensable function
of the Fe–O–Fe center in the hemerythrin domain of FBXL5 [10,11].
Conceivably, a threshold of oxygen is necessary for assembly of the
Fe–O–Fe center in FBXL5 and IRP2 degradation, and this builds up
during prolonged (8 h) exposure of cells to 0.1% O2 (Fig. 1A, lane
19).
Experimental oxidative stress mimics hypoxia with regard to
the stabilization of HIFa subunits [20,25]. In addition, it has been
proposed that the physiological hypoxic stabilization of HIFa re-
quires inhibition of prolyl-hydroxylases by mitochondria-derived
reactive oxygen species (ROS), which are thought to oxidize ferrous
to ferric iron, thereby depleting the enzymes from an essential
cofactor [26,27]. The reducing activity of ascorbate is considered
essential for the replenishment of ferrous iron and activation of
prolyl-hydroxylases. Prompted by earlier data showing at least
partial stabilization of IRP2 by pharmacological inhibitors of pro-
lyl-hydroxylases [15,16], we hypothesized that oxidative stress
may also protect IRP2 against degradation, by analogy to HIFa. In-
deed, treatments of cells with H2O2 or menadione stabilized IRP2
(Figs. 2A and 3A). Moreover, the H2O2-mediated induction of
IRP2 was associated with increased IRE-binding activity (Fig. 2C),
upregulation of TfR1 and decreased ferritin expression (Fig. 2B).
These responses are consistent with stabilization of TfR1 mRNA
and translational inhibition of ferritin mRNA by activated IRP2
[1–3]; the increase of TfR1 expression is also congruous with the
reported IRP-independent stimulation of TfR1 mRNA translation
that is elicited during mild sustained oxidative stress [28].
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ation of oxygen [22], the degradation of a 1 mM H2O2 bolus may
lead to hyperoxia, which would be expected to upregulate FBXL5
and antagonize the stabilization of IRP2. Conceivably, this effect
is transient and does not impinge on IRP2 stability. Alternatively,
an H2O2-dependent oxidation of ferrous to ferric iron may not fa-
vor assembly of the Fe–O–Fe center in FBXL5. The employment
of an established enzymatic system, consisting of glucose, glucose
oxidase and catalase (GOX/CAT system), for the controlled genera-
tion of steady-state H2O2 ﬂuxes and oxygen levels [29] will be
essential to bypass the H2O2 stability issues. The GOX/CAT system
can be used as a tool to determine the dose curve and study the de-
tailed kinetics for IRP2 stabilization by H2O2. In addition, this sys-
tem offers a further advantage as it can be adjusted to non-toxic
concentrations for prolonged time intervals, thereby uncoupling
the redox response of IRP2 from toxic side effects of H2O2.
Our ﬁndings seemingly contradict previous conclusions that
H2O2 promotes rapid induction of IRP1 without affecting IRP2
activity [18]. Early studies did not always take into account the
notorious sensitivity of IRP2 to post-lysis degradation in tissue
and cell extracts [30]. It should also be noted that accumulation
of IRP2 in iron-deﬁcient cells is a combined result of protein stabil-
ization and de novo synthesis [31,32]. Thus, the failure to observe
activation of endogenous IRP2 in H2O2-treated cells that express
very low levels of basal IRP2, may indicate that H2O2 does not af-
fect IRP2 synthesis. Here, we bypassed this experimental limitation
by pretreating Ltk-cells with DFO (Fig. 2C, compare lanes 1–5 and
6–10), an iron chelator that promotes accumulation of endogenous
IRP2. Moreover, we employed H1299 cells engineered for tetracy-
cline-inducible IRP2, which allow to directly assess the effects of
oxidative stress on protein turnover. The data in Figs. 2 and 3A
demonstrate that H2O2 and menadione stabilize IRP2 in the pres-
ence of FAC and provide further evidence that the IRE/IRP system
is amenable to redox control.
Interestingly, the redox-cycling drugs menadione [23] and
doxorubicin [33] have been reported to inhibit the IRE-binding
activity of IRP2. Moreover, oxidative stress generated by glucose
deprivation inactivated IRP2, following oxidation of C512 and
C516, which are predicted to lie within the protein’s IRE-binding
cleft [34]. Conceivably, the oxidant stabilization of IRP2 shown
here is not always coupled to increased IRE-binding activity, espe-
cially under conditions of severe oxidative stress. The chemical
nature of the stressor and the duration of the exposure may be cru-
cial in determining the actual response of IRP2. Experiments with a
more sophisticated oxidative stress-generating system (GOX/CAT)
will likely clarify apparently conﬂicting results and shed more light
to outstanding mechanistic issues and pathophysiological aspects
related to the redox regulation of IRP2.
Antioxidants, such as ascorbate, N-acetyl-cysteine and a-
tocopherol were previously found to induce proteasomal degrada-
tion of IRP2 [16]. Thus, an antioxidant milieu favors IRP2 turnover,
while pro-oxidant conditions protect IRP2. Ascorbate failed to
antagonize IRP2 stabilization by menadione (Fig. 3A), suggesting
a dominance of oxidative stress in this experimental setting. On
the other hand, ascorbate completely reversed IRP2 stabilization
by the hypoxia-mimetic cobalt chloride, which also triggers IRP2
oxidation [12], but was less efﬁcient in decreasing IRP2 levels in
iron-depleted (following DFO treatment) or severely hypoxic cells
(Fig. 3B). Similar results have been reported for HIFa in cells trea-
ted with cobalt chloride or DFO (at the same doses as here), or ex-
posed to 0.4% O2 [35]. Others, however, found that ascorbate
effectively blocks HIFa stabilization under 1% O2, and attributed
the discrepancies to the variable degrees of hypoxia that were used
in the different experimental settings [36]. The failure of ascorbate
to destabilize IRP2 in DFO-treated cells emphasizes the essential
role of iron for IRP2 degradation.The data presented here are in line with a model where iron-
dependent ubiquitination and degradation of IRP2 requires the
activity of FBXL5, which is regulated in an iron and oxygen-depen-
dentmanner [10,11].Wespeculate that the Fe–O–Fe center of FBXL5
maybeamenable to redox control and sensitizedbyoxidative stress.
However, our data do not exclude the possibility for alternative
pathways that may contribute to the redox control of IRP2 stability,
for example involving prolyl-hydroxylases [15,16] or endogenous
heme [37–39]. Dissection of the molecular pathway underlying
the redox regulation of IRP2 awaits further experimentation.
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